Inhibrx Biosciences, Inc. INBX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s common stock shares issued?
- Inhibrx Biosciences, Inc. (INBX) reported common stock shares issued of 14.6M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s common stock shares issued changed year-over-year?
- Inhibrx Biosciences, Inc.'s common stock shares issued increased by 0.9% year-over-year, from 14.5M to 14.6M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s common stock shares issued?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s common stock shares issued has grown at a -44.5% compound annual growth rate (CAGR), from 47.4M to 14.6M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.